Raredr

NORD Goes Live with Q&A about American Health Care Act and Other Policies

Published Online: Thursday, Mar 16, 2017
Tim Boyd and Paul Melmeyer from NORD's policy team were on Facebook Live earlier today. Below is their posting. Tim and Paul talked for over 50 minutes about various policy issues relevant to the rare disease community, including the Affordable Care Act, and its proposed replacement, the American Health Care Act.


For more information, visit www.raredisease.org and visit our NORD partner page at www.raredr.com/sap-partner/nord
 

Latest Articles
Positive initial results from a Phase 1A clinical trial evaluating setmelanotide (RM-492) for the treatment of rare genetic disorders of obesity were reported.
He’s a patient, an educator, and an advocate. Huntington's Disease patient and Bellingham researcher Jeff Carroll is a triple threat.
Dr Gavin Rumbaugh, PhD of Scripps Florida Research Institute was awarded an NIMH-funded grant for the therapeutic development of Syngap1.
Cooper sits down with RDR to talk about A4250, why it’s so important to children with PFIC, and just how Albireo prioritizes treatment for rare diseases.
$vacMongoViewPlus$ $vAR$